Data / Form D filings / Maxwell Biosciences, Inc.
Maxwell Biosciences, Inc.: Form D filings
Maxwell Biosciences, Inc., a biotechnology company in Austin, TX, filed 2 Form D notices with the SEC between 2022 and 2023. The latest, on July 14, 2023, reports an offering of $25 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 3809 Juniper Trace, #101, Austin, TX, 78738
- Phone
- (855) 629-2461
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1907465
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 14, 2023 | New notice | $25,000,000 | $0 | $25,000,000 | 0 | Yet to occur | sec.gov |
| Apr 5, 2022 | New notice | $14,822,750 | $10,850,247 | $3,972,503 | 96 | Oct 4, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joshua McClure | Executive Officer, Director, Promoter | |
| Kate McKinley | Director | |
| Praveen Tyle | Director | |
| Barbara R Holcomb | Director | |
| Annelise Barron | Director |
Other biotechnology companies in Texas that filed recently
- Nuclein, LLC $15.7 million · Oct 27, 2026
- OncoNano Medicine, Inc. $10.1 million · Oct 8, 2026
- Solaris Endovascular Inc. $5 million · Oct 1, 2026
- Hera Biotech, Inc. $1.7 million · Sep 23, 2026
- Kayak Therapeutics, Inc. $25 million · Aug 21, 2026
- InnovoTEX Inc. $2.7 million · Aug 18, 2026
Every Form D from the week of Jul 10, 2023 · All recent filings in Texas · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Maxwell Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.